Comments

Monte Rosa Therapeutics (GLUE) Stock Price, Quote, News & History

GLUENASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$18.66

2.2113.43%

At close: Dec 16, 4:00 PM EST

$18.95

0.291.55%

After Hours: 4:40 PM EST

Why is it moving?

Why Is Monte Rosa Stock Trading Higher Today?

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$17.19

$18.66

Volume / Avg.

3.00M / 1.56M

Day Range

$17.19 - $18.98

52 Wk Range

3.50 - 18.15

Market Cap

$1.23B

P/E Ratio

51.43

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

14.02%

Days to Cover

8.62

Recent Monte Rosa Therapeutics Inc News

Why Is Monte Rosa Stock Trading Higher Today?

Monte Rosa reports interim Phase 1/2 data showing durable responses and manageable safety for MRT-2359 plus Pfizer's Xtandi in advanced prostate cancer patients.

Vandana Singh

Dave & Buster's Entertainment Posts Downbeat Results, Joins Adtran Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$17.19

$18.66

Volume / Avg.

3.00M / 1.56M

Day Range

$17.19 - $18.98

52 Wk Range

3.50 - 18.15

Market Cap

$1.23B

P/E Ratio

51.43

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

14.02%

Days to Cover

8.62

About

Sector

Health Care

Industry

Biotechnology

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutica...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry